Rebecca Larson, MD

Rebecca Larson, MD

Associate Professor of Clinical Internal Medicine, Division of Dermatology
Internal Medicine

    About me

    Academic Interests: Prevention of melanoma and nonmelanoma skin cancer; reconstructive dermatologic surgery; procedural dermatology education; patient safety

    Clinical Interests:  Melanoma and nonmelanoma skin cancer; Mohs Micrographic Surgery; transplant dermatology; medical dermatology; pursuit of the imperceptible surgical scar

    Gender

    Female

    Education & training

    Positions
    Dermatologist
    Board Certifications
    Dermatology
    Medical School
    Loma Linda University School of Medicine, Loma Linda, CA - 2008
    Undergraduate Degree
    Concordia College, Moorehead, MN - 2004
    Residency
    SIU School of Medicine, Springfield, IL - Internal Medicine Internship; Dermatology Residency - 2012
    Fellowship
    University of Wisconsin School of Medicine and Public Health, Madison, WI - Dermatology Fellowship and Mohs Surgery Program - 2014

    Research

    Research Interests
    Cutaneous Oncology, Mohs Micrographic and Dermatologic Surgery, General Dermatology, MOHS Micrographic Surgery.

    Publications

    Cort McCaughey, MD; Juliet Aylward, MD; Jack Longley, MD; Rebecca Larson, MD. “An Enlarging Soft Tissue Mass on the Nose of a 20-year-old Male. Presentation of a Rhabdomyomatous Mesenchymal Hamartoma and Review of the Literature” Dermatologic Surgery 2013 Dec:39(12):1835-1842

    Rebecca Larson, MD and Juliet Aylward, MD. “Evaluation and Management of Hypertension in the Perioperative Period of Mohs Micrographic Surgery: A Review”. Dermatologic Surgery 2014 Jun;40(6):603-609.

    Clinical trials

    Trial
    Dermatology

    Corrona Psoriasis (PSO) Registry

    Active recruiting

    The objective of the Corrona Psoriasis Registry is to create a national database of patients with psoriasis. Data collected will be used to study the  disease and to evaluate the effectiveness and safety of medications approved for the treatment of psoriasis.

    Contact: Rebecca Coughlin 217-545-7321
    Trial
    Dermatology

    A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

    Active not recruiting

    The purpose of this study is to evaluate the long-term safety, tolerability, and effectiveness of PF-06651600(Ritlecitinib) in adult and adolescent (12 years and older) participants with Alopecia Areata.

    Contact: Rebecca Coughlin 217-545-7321